Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
- PMID: 16944309
- DOI: 10.1007/s11060-006-9241-y
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Abstract
Concurrent temozolomide (TMZ) and radiotherapy is the new standard of care for patients with newly diagnosed glioblastoma. In 51 consecutive patients treated according to this regimen, 7 patients (14%) manifested surgically confirmed early necrosis without evidence of recurrent tumor. This observation suggests that daily TMZ may represent a potent radiosensitizing regimen.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical